0000950170-25-076435.txt : 20250522 0000950170-25-076435.hdr.sgml : 20250522 20250522170016 ACCESSION NUMBER: 0000950170-25-076435 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250521 FILED AS OF DATE: 20250522 DATE AS OF CHANGE: 20250522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PYSZCZYMUKA GREG CENTRAL INDEX KEY: 0001952920 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36075 FILM NUMBER: 25978049 MAIL ADDRESS: STREET 1: C/O AYTU BIOPHARMA, INC. STREET 2: 373 INVERNESS PARKWAY, SUITE 206 CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER NAME: FORMER CONFORMED NAME: PYSZCAYMUKA GREG DATE OF NAME CHANGE: 20221031 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evoke Pharma Inc CENTRAL INDEX KEY: 0001403708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 208447886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: 858-345-1494 MAIL ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 4 1 ownership.xml 4 X0508 4 2025-05-21 0001403708 Evoke Pharma Inc EVOK 0001952920 PYSZCZYMUKA GREG C/O EVOKE PHARMA, INC. 420 STEVENS AVENUE, SUITE 230 SOLANA BEACH CA 92075 true false false false false Stock Option (Right to Buy) 3.453 2025-05-21 4 A false 1155 0 A 2035-05-20 Common Stock 1155 6988 D The total number of shares of common stock subject to the option vests on the one-year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. /s/ Matthew J. D'Onofrio, Attorney-in-fact for Greg Pyszczymuka 2025-05-22